{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T12:03:01Z","timestamp":1794830581342,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1208\/s12248-020-00442-3","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T21:02:53Z","timestamp":1584565373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Structure-Based Design and Discovery of a Long-Acting Cocaine Hydrolase Mutant with Improved Binding Affinity to Neonatal Fc Receptor for Treatment of Cocaine Abuse"],"prefix":"10.1208","volume":"22","author":[{"given":"Fang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiabin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungbo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"issue":"5103","key":"442_CR1","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1126\/science.8456315","volume":"259","author":"DW Landry","year":"1993","unstructured":"Landry DW, Zhao K, Yang GX, Glickman M, Georgiadis TM. Antibody-catalyzed degradation of cocaine. Science. 1993;259(5103):1899\u2013901.","journal-title":"Science"},{"key":"442_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.1221691","volume":"336","author":"AL Milton","year":"2012","unstructured":"Milton AL, Everitt BJ. Wiping drug memories. Science. 2012;336:167\u20138.","journal-title":"Science"},{"key":"442_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1126\/science.1214463","volume":"335","author":"KD Ersche","year":"2012","unstructured":"Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET. Abnormal brain structure implicated in stimulant drug addiction. Science. 2012;335:601\u20134.","journal-title":"Science"},{"key":"442_CR4","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2165\/00003495-200464140-00004","volume":"64","author":"DA Gorelick","year":"2004","unstructured":"Gorelick DA, Gardner EL, Xi ZX. Agents in development for the management of cocaine abuse. Drugs. 2004;64:1547\u201373.","journal-title":"Drugs"},{"issue":"45","key":"442_CR5","doi-asserted-by":"publisher","first-page":"15057","DOI":"10.1021\/jp900963n","volume":"113","author":"X Huang","year":"2009","unstructured":"Huang X, Gu HH, Zhan C-G. Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations. J Phys Chem B. 2009;113(45):15057\u201366.","journal-title":"J Phys Chem B"},{"key":"442_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1021\/acschemneuro.5b00001","volume":"6","author":"Y Yuan","year":"2015","unstructured":"Yuan Y, Huang X, Midde NM, Quizon PM, Sun WL, Zhu J, et al. Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter. ACS Chem Neurosci. 2015;6:658\u201365.","journal-title":"ACS Chem Neurosci"},{"key":"442_CR7","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.4155\/fmc-2016-0138","volume":"8","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Huang X, Zhu J, Zhan C-G. Computational modeling of human dopamine transporter structures, mechanism and its interaction with HIV-1 transactivator of transcription. Future Med Chem. 2016;8:2077\u201389.","journal-title":"Future Med Chem"},{"key":"442_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2174\/187152731406150624122404","volume":"14","author":"P Skolnick","year":"2015","unstructured":"Skolnick P, White D, Acri JB. Editorial: emerging targets for stimulant use disorders: where to invest in an era of constrained resources? CNS Neurol Disord Drug Targets. 2015;14:691.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"442_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4155\/fmc.09.20","volume":"1","author":"F Zheng","year":"2009","unstructured":"Zheng F, Zhan C-G. Recent progress in protein drug design and discovery with a focus on novel approaches to the development of anti-cocaine medications. Future Med Chem. 2009;1:515\u201328.","journal-title":"Future Med Chem"},{"key":"442_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4155\/fmc.10.275","volume":"3","author":"F Zheng","year":"2011","unstructured":"Zheng F, Zhan C-G. Enzyme therapy approaches for treatment of drug overdose and addiction. Future Med Chem. 2011;3:9\u201313.","journal-title":"Future Med Chem"},{"key":"442_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4155\/fmc.11.171","volume":"4","author":"F Zheng","year":"2012","unstructured":"Zheng F, Zhan C-G. Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose? Future Med Chem. 2012;4:125\u20138.","journal-title":"Future Med Chem"},{"key":"442_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002610","volume":"8","author":"F Zheng","year":"2012","unstructured":"Zheng F, Zhan C-G. Modeling of pharmacokinetics of cocaine in human reveals the feasibility for development of enzyme therapies for drugs of abuse. PLoS Comput Biol. 2012;8:e1002610.","journal-title":"PLoS Comput Biol"},{"key":"442_CR13","doi-asserted-by":"publisher","first-page":"7477","DOI":"10.1039\/c3ob41713a","volume":"11","author":"S Hou","year":"2013","unstructured":"Hou S, Xue L, Yang W, Fang L, Zheng F, Zhan C-G. Substrate selectivity of high-activity mutants of human butyrylcholinesterase. Org Biomol Chem. 2013;11:7477\u201385.","journal-title":"Org Biomol Chem"},{"issue":"2","key":"442_CR14","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1586\/17512433.1.2.277","volume":"1","author":"DA Gorelick","year":"2008","unstructured":"Gorelick DA. Pharmacokinetic approaches to treatment of drug addiction. Expert Rev Clin Pharmacol. 2008;1(2):277\u201390.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"442_CR15","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1021\/ja020850+","volume":"125","author":"C-G Zhan","year":"2003","unstructured":"Zhan C-G, Zheng F, Landry DW. Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase. J Am Chem Soc. 2003;125:2462\u201374.","journal-title":"J Am Chem Soc"},{"issue":"2","key":"442_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1124\/mol.62.2.220","volume":"62","author":"H Sun","year":"2002","unstructured":"Sun H, Pang Y-P, Lockridge O, Brimijoin S. Re-engineering butyrylcholinesterase as a cocaine hydrolase. Mol Pharmacol. 2002;62(2):220\u20134.","journal-title":"Mol Pharmacol"},{"issue":"46","key":"442_CR17","doi-asserted-by":"publisher","first-page":"16656","DOI":"10.1073\/pnas.0507332102","volume":"102","author":"Y Pan","year":"2005","unstructured":"Pan Y, Gao D, Yang W, Cho H, Yang G, Tai H-H, et al. Computational redesign of human butyrylcholinesterase for anticocaine medication. Proc Natl Acad Sci U S A. 2005;102(46):16656\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"36","key":"442_CR18","doi-asserted-by":"publisher","first-page":"12148","DOI":"10.1021\/ja803646t","volume":"130","author":"F Zheng","year":"2008","unstructured":"Zheng F, Yang WC, Ko MC, Liu JJ, Cho H, Gao DQ, et al. Most efficient cocaine hydrolase designed by virtual screening of transition states. J Am Chem Soc. 2008;130(36):12148\u201355.","journal-title":"J Am Chem Soc"},{"key":"442_CR19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1124\/mol.110.068494","volume":"79","author":"L Xue","year":"2011","unstructured":"Xue L, Ko M-C, Tong M, Yang W, Hou S, Fang L, et al. Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine. Mol Pharmacol. 2011;79:290\u20137.","journal-title":"Mol Pharmacol"},{"key":"442_CR20","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1388\/ncomms4457","volume":"5","author":"F Zheng","year":"2014","unstructured":"Zheng F, Xue L, Hou S, Liu J, Zhan M, Yang W, et al. A highly efficient cocaine-detoxifying enzyme obtained by computational design. Nat Commun. 2014;5:3457. https:\/\/doi.org\/10.1388\/ncomms4457.","journal-title":"Nat Commun"},{"key":"442_CR21","doi-asserted-by":"publisher","first-page":"9113","DOI":"10.1021\/bi1011628","volume":"49","author":"F Zheng","year":"2010","unstructured":"Zheng F, Yang W, Xue L, Hou S, Liu J, Zhan C-G. Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency. Biochemistry. 2010;49:9113\u20139.","journal-title":"Biochemistry"},{"key":"442_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/BJ20131100","volume":"457","author":"M Zhan","year":"2014","unstructured":"Zhan M, Hou S, Zhan C-G, Zheng F. Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine. Biochem J. 2014;457:197\u2013206.","journal-title":"Biochem J"},{"key":"442_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/BJ20140360","volume":"460","author":"S Hou","year":"2014","unstructured":"Hou S, Zhan M, Zheng X, Zhan C-G, Zheng F. Kinetic characterization of human butyrylcholinesterase mutants for hydrolysis of cocaethylene. Biochem J. 2014;460:447\u201357.","journal-title":"Biochem J"},{"issue":"1\u20133","key":"442_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cbi.2010.01.004","volume":"187","author":"W Yang","year":"2010","unstructured":"Yang W, Xue L, Fang L, Chen X, Zhan C-G. Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine. Chem Biol Interact. 2010;187(1\u20133):148\u201352.","journal-title":"Chem Biol Interact"},{"key":"442_CR25","doi-asserted-by":"publisher","first-page":"15303","DOI":"10.1038\/s41598-017-14105-5","volume":"7","author":"T Zhang","year":"2017","unstructured":"Zhang T, Zheng X, Zhou Z, Chen X, Jin Z, Deng J, et al. Clinical potential of an enzyme-based novel therapy for cocaine overdose. Sci Rep. 2017;7:15303.","journal-title":"Sci Rep"},{"key":"442_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1208\/s12248-017-0167-4","volume":"20","author":"X Zheng","year":"2018","unstructured":"Zheng X, Zhou Z, Zhang T, Jin Z, Chen X, Deng J, et al. Effectiveness of a cocaine hydrolase for cocaine toxicity treatment in male and female rats. AAPS J. 2018;20:3\u20137. https:\/\/doi.org\/10.1208\/s12248-017-0167-4.","journal-title":"AAPS J"},{"issue":"11","key":"442_CR27","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1038\/sj.npp.1301666","volume":"33","author":"S Brimijoin","year":"2008","unstructured":"Brimijoin S, Gao Y, Anker JJ, Gliddon LA, LaFleur D, Shah R, et al. A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats. Neuropsychopharmacology. 2008;33(11):2715\u201325.","journal-title":"Neuropsychopharmacology"},{"key":"442_CR28","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jcph.450","volume":"55","author":"O Cohen-Barak","year":"2015","unstructured":"Cohen-Barak O, Wildeman J, van de Wetering J, Hettinga J, Schuilenga-Hut P, Gross A, et al. Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects. J Clin Pharmacol. 2015;55:573\u201383.","journal-title":"J Clin Pharmacol"},{"key":"442_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/JCP.0000000000000320","volume":"35","author":"MJ Shram","year":"2015","unstructured":"Shram MJ, Cohen-Barak O, Chakraborty B, Bassan M, Schoedel KA, Hallak H, et al. Assessment of pharmacokinetic and pharmacodynamic interactions between albumin-fused mutated butyrylcholinesterase and intravenously administered cocaine in recreational cocaine users. J Clin Psychopharmacol. 2015;35:396\u2013405.","journal-title":"J Clin Psychopharmacol"},{"key":"442_CR30","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1038\/522S53a","volume":"522","author":"C Willyard","year":"2015","unstructured":"Willyard C. Quest for the quitting pill. Nature. 2015;522:S53.","journal-title":"Nature"},{"key":"442_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.drugalcdep.2016.05.019","volume":"166","author":"Y Gilgun-Sherki","year":"2016","unstructured":"Gilgun-Sherki Y, Eliaz RE, McCann DJ, Loupe PS, Eyal E, Blatt K, et al. Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence. Drug Alcohol Depend. 2016;166:13\u201320.","journal-title":"Drug Alcohol Depend"},{"key":"442_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.drugalcdep.2018.01.033","volume":"188","author":"L Shemesh-Darvish","year":"2018","unstructured":"Shemesh-Darvish L, Shinar D, Hallak H, Gross A, Rosenstock M. TV-1380 attenuates cocaine-induced changes in cardiodynamic parameters in monkeys and reduces the formation of cocaethylene. Drug Alcohol Depend. 2018;188:295\u2013303.","journal-title":"Drug Alcohol Depend"},{"key":"442_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1369-1600.2011.00424.x","volume":"18","author":"CW Schindler","year":"2013","unstructured":"Schindler CW, Justinova Z, Lafleur D, Woods D, Roschke V, Hallak H, et al. Modification of pharmacokinetic and abuse-related effects of cocaine by human-derived cocaine hydrolase in monkeys. Addict Biol. 2013;18:30\u20139.","journal-title":"Addict Biol"},{"key":"442_CR34","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1038\/npp.2014.3","volume":"39","author":"NE Zlebnik","year":"2014","unstructured":"Zlebnik NE, Brimijoin S, Gao Y, Saykao AT, Parks RJ, Carroll ME. Long-term reduction of cocaine self-administration in rats treated with adenoviral vector-delivered cocaine hydrolase: evidence for enzymatic activity. Neuropsychopharmacology. 2014;39:1538\u201346.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"442_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41551-018-0293-z","volume":"3","author":"Yuanyuan Li","year":"2018","unstructured":"Li Y, Kong Q, Yue J, Gou X, Xu M, Wu X. Genome-edited skin epidermal stem cells protect mice from cocaine-seeking behaviour and cocaine overdose. Nat Biomed Eng. 2019;3(2):105\u2013113.","journal-title":"Nature Biomedical Engineering"},{"key":"442_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1208\/s12248-019-0377-z","volume":"22","author":"Y Cai","year":"2019","unstructured":"Cai Y, Zhou S, Jin Z, Wei H, Shang L, Deng J, et al. Reengineering of albumin-fused cocaine hydrolase CocH1 (TV-1380) to prolong its biological half-life. AAPS J. 2019;22:5\u201311. https:\/\/doi.org\/10.1208\/s12248-019-0377-z.","journal-title":"AAPS J"},{"key":"442_CR37","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1073\/pnas.1517713113","volume":"113","author":"X Chen","year":"2016","unstructured":"Chen X, Xue L, Hou S, Jin Z, Zhang T, Zheng F, et al. Long-acting cocaine hydrolase for addiction therapy. Proc Natl Acad Sci U S A. 2016;113:422\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"442_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cbi.2019.04.012","volume":"306","author":"X Chen","year":"2019","unstructured":"Chen X, Deng J, Zheng X, Zhang J, Zhou Z, Wei H, et al. Development of a long-acting Fc-fused cocaine hydrolase with improved yield of protein expression. Chem Biol Interact. 2019;306:89\u201395.","journal-title":"Chem Biol Interact"},{"key":"442_CR39","unstructured":"Schrodinger LLC. The PyMOL molecular graphics system, Version 1.8. 2015."},{"issue":"3","key":"442_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20130013","volume":"453","author":"F Nachon","year":"2013","unstructured":"Nachon F, Carletti E, Ronco C, Trovaslet M, Nicolet Y, Jean L, et al. Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl-and butyryl-cholinesterase. Biochem J. 2013;453(3):393\u20139.","journal-title":"Biochem J"},{"issue":"11","key":"442_CR41","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1074\/jbc.M113.537563","volume":"289","author":"V Oganesyan","year":"2014","unstructured":"Oganesyan V, Damschroder MM, Cook KE, Li Q, Gao C, Wu H, et al. Structural insights into neonatal Fc receptor-based recycling mechanisms. J Biol Chem. 2014;289(11):7812\u201324.","journal-title":"J Biol Chem"},{"issue":"2","key":"442_CR42","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys. 1983;79(2):926\u201335.","journal-title":"J Chem Phys"},{"key":"442_CR43","unstructured":"Case, D. A.; Betz, R. M.; Cerutti, D. S.; Cheatham, I. T. E.; Darden, T. A.; Duke, R. E.; Giese, T. J.; Gohlke, H.; Goetz, A. W.; Homeyer, N.; Izadi, S.; Janowski, P.; Kaus, J.; Kovalenko, A.; Lee, T. S.; LeGrand, S.; Li, P.; Lin, C.; Luchko, T.; Luo, R.; Madej, B.; Mermelstein, D.; Merz, K. M.; Monard, G.; Nguyen, H.; Nguyen, H. T.; Omelyan, I.; Onufriev, A.; Roe, D. R.; Roitberg, A.; Sagui, C.; Simmerling, C. L.; Botello-Smith, W. M.; Swails, J.; Walker, R. C.; Wang, J.; Wolf, R. M.; Wu, X.; Xiao, L.; Kollman, P. A., AMBER 16, University of California, San Francisco. 2016."},{"issue":"9","key":"442_CR44","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller III","year":"2012","unstructured":"Miller BR III, McGee TD Jr, Swails JM, Homeyer N, Gohlke H, Roitberg AE. MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput. 2012;8(9):3314\u201321.","journal-title":"J Chem Theory Comput"},{"key":"442_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0167-4838(99)00115-6","volume":"1433","author":"P Masson","year":"1999","unstructured":"Masson P, Xie W, Froment M-T, Levitsky V, Fortier P-L, Albaret C, et al. Interaction between the peripheral site residues of human butyrylcholinesterase, D70 and Y332, in binding and hydrolysis of substrates. Biochim Biophys Acta. 1999;1433:281\u201393.","journal-title":"Biochim Biophys Acta"},{"key":"442_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1042\/BJ20130549","volume":"453","author":"L Xue","year":"2013","unstructured":"Xue L, Hou S, Tong M, Fang L, Chen X, Jin Z, et al. Preparation and in vivo characterization of a cocaine hydrolase engineered from human butyrylcholinesterase for metabolizing cocaine. Biochem J. 2013;453:447\u201354.","journal-title":"Biochem J"},{"issue":"1","key":"442_CR47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pep.2011.03.012","volume":"79","author":"Y Feng","year":"2011","unstructured":"Feng Y, Gong R, Dimitrov DS. Design, expression and characterization of a soluble single-chain functional human neonatal Fc receptor. Protein Expr Purif. 2011;79(1):66\u201371.","journal-title":"Protein Expr Purif"},{"key":"442_CR48","first-page":"nihms5095","volume":"3","author":"O Lockridge","year":"2005","unstructured":"Lockridge O, Schopfer LM, Winger G, Woods JH. Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys; a potential new therapeutic for protection against cocaine and nerve agent toxicity. J Med Chem Biol Radiol Def. 2005;3:nihms5095.","journal-title":"J Med Chem Biol Radiol Def"},{"key":"442_CR49","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1021\/acs.analchem.5b03900","volume":"88","author":"YY Fan","year":"2016","unstructured":"Fan YY, Neubert H. Quantitative analysis of human neonatal Fc receptor (FcRn) tissue expression in transgenic mice by online peptide immuno-affinity LC-HRMS. Anal Chem. 2016;88:4239\u201347.","journal-title":"Anal Chem"},{"key":"442_CR50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/pgmj.2006.055970","volume":"83","author":"SD Treadwell","year":"2007","unstructured":"Treadwell SD, Robinson TG. Cocaine use and stroke. Postgrad Med J. 2007;83:389\u201394.","journal-title":"Postgrad Med J"},{"key":"442_CR51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri2155","volume":"7","author":"DC Roopenian","year":"2007","unstructured":"Roopenian DC, Akilesh S. FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol. 2007;7:715\u201325.","journal-title":"Nat Rev Immunol"},{"key":"442_CR52","doi-asserted-by":"publisher","first-page":"16020","DOI":"10.1021\/jp1086416","volume":"114","author":"B Yang","year":"2010","unstructured":"Yang B, Hamza A, Wang Y, Chen G, Zhan C-G. Computational determination of binding structures and free energies of phosphodiesterase-2 with benzo[1,4]diazepin-2-one derivatives. J Phys Chem B. 2010;114:16020\u20138.","journal-title":"J Phys Chem B"},{"key":"442_CR53","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1210\/jcem-70-3-601","volume":"70","author":"C Campino","year":"1990","unstructured":"Campino C, Szecowka J, Michelsen H, Ser\u00f3n-Ferr\u00e9 M. Certain large forms of circulating immunoreactive human growth hormone are in fact immunoglobulins. J Clin Endocrinol Metab. 1990;70:601\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"442_CR54","unstructured":"EMA, ORENCIA, INN: abatecept - European Medicines Agency (https:\/\/www.ema.europa.eu\/en\/documents\/scientific-discussion\/orencia-epar-scientific-discussion_en.pdf)."},{"key":"442_CR55","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1172\/JCI81722","volume":"125","author":"MR Rigby","year":"2015","unstructured":"Rigby MR, Harris KM, Pinckney A, DiMeglio LA, Rendell MS, Felner EI, et al. Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients. J Clin Invest. 2015;125:3285\u201396.","journal-title":"J Clin Invest"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-020-00442-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-020-00442-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-020-00442-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:04:29Z","timestamp":1616025869000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-020-00442-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["442"],"URL":"https:\/\/doi.org\/10.1208\/s12248-020-00442-3","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"10 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal procedures used in this project were approved by the Institutional Animal Care and Use Committee (IACUC).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"62"}}